Loading...
A study found 34% of mesh reconstruction patients experienced complications. Take our quick quiz to see if you qualify for compensation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Women who received surgical mesh — marketed as an "internal bra" — during breast reconstruction, augmentation, or lift procedures may qualify for a breast mesh lawsuit. The FDA has not approved surgical mesh for breast surgeries, meaning all such use is considered off-label.
Manufacturers including Allergan, C.R. Bard, and Integra Life Sciences have been accused of inadequate warnings, insufficient testing, and off-label marketing. A study published in The Breast journal found that 34% of 154 mesh reconstruction patients experienced complications, with 13% requiring surgical removal — and those complications are the basis of the current surgical mesh lawsuit claims being reviewed nationwide.
Breast mesh complications can be serious and life-altering. Common symptoms include:
As plastic surgeon Dr. Robert Schwartz notes: "The body could react to foreign mesh material, leading to infection serious enough to require removal, necessitating additional surgeries and longer recovery."
If you experienced any of these issues after a mesh-assisted breast procedure, you may have grounds for a surgical mesh lawsuit.
Reported complications include chronic pain, scar tissue hardening, and reconstructive failure. Galaflex lawsuit claims are being reviewed nationwide.
Reported complications include infection, seroma, and implant-site breakdown. Allomax lawsuit cases are being reviewed nationwide.
Reported complications include capsular contracture, deformity, and revision surgery. Strattice lawsuit claims are being reviewed nationwide.
Reported complications include tissue rejection, chronic pain, and reconstructive failure. AlloDerm lawsuit cases are being reviewed nationwide.
Reported complications include infection, hematoma, and mesh-related revision surgery. SurgiMend lawsuit claims are being reviewed nationwide.
Reported complications include breakdown of mesh material, chronic pain, and secondary surgery. Phasix lawsuit cases are being reviewed nationwide.
Reported complications include infection, seroma, and reconstructive failure. FlexHD lawsuit claims are being reviewed nationwide.
Reported complications include mesh failure, chronic inflammation, and revision surgery. DuraSorb lawsuit cases are being reviewed nationwide.
You may qualify for a breast mesh lawsuit if you:
Brands involved in the breast mesh lawsuit include AlloDerm, Allomax, DuraSorb, FlexHD, Galaflex, Phasix, Strattice, and SurgiMend — manufactured by Allergan / Lifecell, C.R. Bard, Integra Life Sciences, MTF Biologics, and Galatea Surgical.
Time is limited — statutes of limitations for a surgical mesh lawsuit vary by state. Contact us today for a free case review.
RecoverMore is a legal marketing service. We are not a law firm. We connect qualified claimants with independent attorneys at no cost.
There is no upfront cost to using the attorneys and the consultation is fully confidential. No win, no fee.